Cong Ty Co Phan Tscare announced that it expects to receive KRW 39.115606503 billion in funding from Dongwha Pharm.Co.,Ltd
August 02, 2023
Share
TSCARE JOINT STOCK COMPANY announced a private placement to issue 12,154,142 common shares at a price of KRW 3218.294348 per share for gross proceeds of KRW 39,115,606,503 on August 3, 2023. The transaction will include participation from new investor Dongwha Pharm.Co.,Ltd and have the right to purchase up to 80% of the shares from existing shareholders. The transaction has been approved by the board of directors of the company.
The transaction is expected to close on October 31, 2023.
DONGWHA PHARM.CO., LTD is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products consist of ethical drugs, including digestive system remedies, antibiotics, cardiovascular and metabolic disease treatments, non steroidal anti-inflammatory drugs, respiratory remedies, muscle relaxants, nervous system remedies, dermatological remedies and urinary system remedies, and over-the-counter (OTC) drugs, including cold remedies, dental remedies, dermatological remedies, hepatic protectors, nutrients, tonics, topical analgesics, anti-smoking agents and others. It also provides medicine raw materials, health food and drinks, as well as cosmetics. The Company distributes its products within domestic market and to overseas markets.
DONGWHA PHARM.CO.,LTD 
